Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune Responses
John L. Marshall(Georgetown University), Jeffrey Schlom(National Cancer Institute), Mary Ann Toomey(Georgetown University), Kristen Faraguna(Georgetown University), Ellen Richmond(Georgetown University), Philip M. Arlen(Dana-Farber Cancer Institute), Kwong Y. Tsang(National Cancer Institute), Edmund A. Gehan(Georgetown University), Ronald A. Peck(Georgetown University), Ping Chang(Georgetown University), Robert J. Hoyer(Georgetown University), James E. Pedicano(Georgetown University)
Cited by 357
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
|Nature|2011|1.3k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973